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ARTICLE		
Ultraspecific	live	imaging	of	the	dynamics	of	zebrafish	neutrophil	granules	
by	a	histopermeable	fluorogenic	benzochalcone	probe		
Emma	Colucci-Guyon1,2,*,	Ariane	S.	Batista3,Ɨ,	Suellen	D.	S.	Oliveira4,Ɨ,	Magali	Blaud5,	Ismael	C.	Bellettini6,		Benoit	
S.	Marteyn7,8,	Karine	Leblanc9,	Philippe	Herbomel1,2	&	Romain	Duval10,*		
Neutrophil	granules	(NGs)	are	key	components	of	the	innate	immune	response	and	mark	the	development	of	the	hematopoietic	system	
in	mammals.	However,	no	specific	fluorescent	vital	stain	existed	up	to	now	to	monitor	their	dynamics	within	a	whole	live	organism.	We	
rationally	 designed	 a	 benzochalcone	 fluorescent	 probe	 (HAB)	 featuring	 high	 tissue	 permeability	 and	 optimal	 photophysics	 such	 as	
elevated	quantum	yield,	 pronounced	 solvatochromism	and	 target-induced	 fluorogenesis.	 Phenotypic	 screening	 identified	HAB	as	 the	
first	 cell-	 and	 organelle-specific	 small-molecule	 tracer	 of	 NGs	 in	 live	 zebrafish	 larvae,	 with	 no	 labeling	 of	 any	 other	 cell	 types	 or	
organelles.	HAB	staining	was	independent	of	the	state	of	neutrophil	activation,	 labeling	NGs	of	both	resting	and	phagocytically-active	
cells	with	 equal	 specificity.	 By	 high-resolution	 live	 imaging,	we	 documented	 the	 dynamics	 of	 HAB-stained	NGs	 during	 phagocytosis.	
Upon	 zymosan	 injection,	 labeled	NGs	were	 rapidly	 recruited	 to	 the	 forming	 phagosome	 in	 live	 zebrafish	 phagocytosing	 neutrophils.	
Despite	 being	 a	 reversible	 ligand,	 HAB	 could	 not	 be	 displaced	 by	 high	 concentrations	 of	 pharmacologically-relevant	 competing	
chalcones,	indicating	that	this	specific	labeling	was	the	result	of	HAB	precise	physicochemical	signature	rather	than	a	general	feature	of	
chalcones.	 However,	 one	 of	 the	 competitors	 was	 discovered	 as	 a	 promising	 interstitial	 fluorescent	 tracer	 illuminating	 zebrafish	
histology,	similarly	to	BODIPY-ceramide.	As	a	yellow-emitting	histopermeable	vital	stain,	HAB	functionally	and	spectrally	complements	
most	genetically-incorporated	 fluorescent	 tags	 commonly	used	 in	 live	 zebrafish	biology,	holding	promise	 for	 the	 study	of	neutrophil-
dependent	 responses	 relevant	 to	 human	 physiopathology	 such	 as	 developmental	 defects,	 inflammation	 and	 infection.	 Furthermore,	
HAB	 intensely	 labeled	 isolated	 live	 human	 neutrophils	 at	 the	 level	 of	 granulated	 subcellular	 structures	 consistent	with	 human	NGs,	
suggesting	that	the	labeling	of	NGs	by	HAB	is	not	restricted	to	the	zebrafish	model	but	also	relevant	to	mammalian	systems.	
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The	zebrafish	(Danio	rerio),	a	precious	vertebrate	model	in	developmental	biology,	has	recently	emerged	as	a	powerful	non-
mammalian	 model	 to	 study	 the	 development	 and	 the	 function	 of	 the	 immune	 system	 and	 to	 address	 host-pathogen	
interaction	 in	the	context	of	an	entire	 live	organism.	The	small	size	and	the	natural	translucency	of	the	zebrafish	embryo	
and	 swimming	 larva	make	 it	 possible	 to	 follow	 leukocyte	 deployment,	 behavior	 and	 functions	 in	 vivo	 at	 high	 resolution	
throughout	the	organism.1,	2	Maturation	and	deployment	of	myeloid	cell	lineages	have	been	characterized	for	more	than	a	
decade.	 The	 zebrafish	 possesses	 a	 multi-lineage	 myeloid	 compartment	 with	 two	 types	 of	 granulocytes	
(heterophil/neutrophil	and	eosinophil	granulocytes),	and	monocyte/macrophages,	each	with	characteristic	morphological	
and	histochemical	 features.	Macrophages	appears	during	the	first	day	of	zebrafish	development,	 followed	by	neutrophils	
that	 arise	 a	 day	 later,	 both	 leukocytes	 representing	 together	 a	 first,	 efficient	 immune	 system	 for	 the	 developing	 fish.3-5	
Zebrafish	neutrophils	are	morphologically	and	functionally	similar	to	their	mammalian	counterpart.	They	are	equipped	with	
granules	 containing	 microbicidal	 compounds,	 they	 engulf	 and	 kill	 invading	 microorganisms,	 and	 have	 been	 extensively	
studied	for	their	key	roles	in	innate	immunity	and	inflammation.	The	availability	of	transgenic	fish	lines	expressing	GFP	or	
other	fluorescent	proteins	under	the	control	of	specific	neutrophil	promoters	allows	the	live	imaging	of	neutrophil	behavior	
in	 the	 context	 of	 the	 entire	 organism.6,	 7	 Although	 several	 small-molecule	 tracers	 of	 neutrophil	 granules	 have	 been	
described	 (e.	 g.,	 quinacrine,	 LysoTrackerRed®,	 fluorescent	 tyramide	 conjugates	 or	 Sudan	 Black	 staining	 for	 endogenous	
peroxidase	containing	granules),	they	are	either	non-specific	in	terms	of	labeled	organelles	or	limited	to	fixed	samples	and	
therefore	unusable	as	vital	stains	for	live	animal	imaging.5,	8,	9	
In	our	development	of	 fluorescent	organic	dyes	 for	biological	applications,	we	 searched	 for	 small	 size,	non-canonical	
fluorophores	with	novel	structure-fluorescence	relationships	(SFRs)10,	and	identified	the	chalcone	scaffold	as	such	a	motif.	
Chalcones	 (1,3-diphenyl-2-propen-1-ones)	 have	 been	 investigated	 as	 fluorescent	 chemosensors	 for	 several	 analytical	
applications,11-13	 and	 as	 pharmacological	 probes	 in	 a	 few	 cases.14-17	 However,	 their	 development	 as	 fluotracers	 has	
remained	hampered	by	suboptimal	photophysics	such	as	minute	to	modest	quantum	yields,11-13	by	poor	cytopermeabilities	
limiting	 biological	 labeling	 to	 cell	 surfaces14,	 15	 or	 extracellular	 deposits,17	 by	 substantial	 non-specific	 labeling,16	 and	 by	
weakly	documented	SFRs.14-16,	18	These	constitute	severe	drawbacks	for	potential	fluorophores	that	are	otherwise	compact,	
easy	to	synthesize	and	also	spectrally	tractable	by	chemical	modulation.	They	define	the	challenges	to	be	addressed	in	the	
design	of	an	optimal	chalcone	probe	for	biological	studies.	
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Results	
Probe	synthesis	and	fluorescence	structure-activity	relationships.	Chalcone	itself	 is	 intrinsically	non-fluorescent.	Towards	
emissive	 chalcones	 possessing	 optimal	 photophysics	 and	 high	 cytopermeability	 for	 live-cell	 and	 live-animal	 imaging,	 we	
rationally	delineated	minimal	structural	modifications	of	the	1,3-diarylpropenone	system	(Scheme	1).	Organic	fluorophores	
are	classically	composed	of	push-pull	moieties	connected	by	means	of	an	extended	conjugation,	allowing	efficient	excited	
state	intramolecular	charge	transfers	(ICTs).10	Accordingly,	an	electrodonating	aromatic	ring	(B)	would	be	conjugated	to	the	
enone	 system,	 with	 the	 arylcarbonyle	 (A)	 acting	 as	 electron-withdrawing	 moiety	 in	 the	 chalcone	 system	 (Fig.	 1).	 The	
electrodonating	 aryle	 was	 chosen	 as	 a	 naphtyle	 group,	 known	 to	 increase	 fluorescence	 intensity	 while	 exerting	
bathochromic	effects	with	 respect	 to	 the	phenyle	group.10, 19	 This	 shift	 is	useful	 for	microscopic	 imaging	as	 it	diminishes	
light	scattering,	cellular	auto-fluorescence	and	phototoxicity.20, 21	In	addition,	the	more	lipophilic	naphthyle	nucleus	would	
dramatically	increase	the	ability	of	a	given	probe	to	penetrate	cells	and	organelles.	We	finally	settled	on	a	pivotal	primary	
amino	 group	 as	 the	 electrodonating	 substituent,	 having	 in	 mind	 its	 useful	 transformation	 to	 the	 azide	 for	 fluorogenic	
photolabeling	strategies	of	cells	or	proteomes.22	Accordingly,	we	targeted	the	3-aminobenzochalcone	core	as	the	optimal	
fluorophore	in	this	series,	featuring	the	most	extended	captodative	system,	and	expected	to	display	maximal	fluorescence	
intensity	and	bathochromism	(Fig.	1).			
	
	
Figure	 1	 Stepwise	 design	 of	 a	 minimal	 cytopermeable	 chalcone	 fluorophore	 (EWG,	 electro-withdrawing	 group;	 EDG,	
electro-donating	group;	R,	any	substituent).	
	
These	 3-aminobenzochalcones	 were	 obtained	 by	 reduction	 of	 the	 corresponding	 nitro	 intermediates,	 accessed	 by	
Claisen-Schmidt	condensation	of	various	acetophenones	with	8-nitro-2-naphthaldehyde	2.	Starting	from	β-naphthaldehyde	
1,23	a	small	library	of	benzochalcones	3-8	was	thus	obtained	where	the	electron	density	of	the	acetophenyle	part	was	tuned	
from	 severely	 deficient	 (R	 =	 4’-CF3)	 to	 strongly	 enriched	 (R	 =	 4’-OH).	 Two	 close	 analogues	 were	 synthesized	 for	 the	
physicochemical	standardization	of	this	new	series:	(i)	5-aminobenzochalcone	12	is	a	regioisomer	of	3-aminobenzochalcone	
8,	 possessing	 a	 less	 extended	 captodative	 system	 as	 a	 pseudo-para	 conjugation;	 (ii)	 2-aminochalcone	 14	 is	 the	 exact	
chalcone	congener	of	3-aminobenzochalcone	6,	and	should	permit	to	quantify	the	influence	of	the	naphthyle	ring	both	in	
terms	 of	 fluorescence	 and	 lipophilicity.	 Compound	 12	 was	 obtained	 from	 β-methylnaphthalene	 9	 upon	 regioselective	
nitration24	then	methyle	oxidation.	The	obtained	6-nitro-2-naphthaldehyde	11	was	turned	to	5-aminobenzochalcone	12	by	
a	 “one-pot”	 condensation-reduction	 as	 for	 aminochalcones	 3-8.	 2-aminochalcone	 14	 was	 obtained	 from	 2-
nitrobenzaldehyde	 13	 following	 the	 same	 strategy	 (Fig.	 2a)	 (see	 Electronic	 Supplementary	 Information	 for	 all	 synthetic	
procedures).	
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Figure	 2	 Synthesis	 of	 representative	 compounds	 in	 the	 3-aminobenzochalcone,	 5-aminobenzochalcone	 and	 2-
aminochalcone	 series	 and	 SFRs	 in	 the	 3-aminobenzochalcone	 series.	 (a)	Reagents	 and	 conditions:	 a)	 HNO3	 (40	 equiv.),	
H2SO4	(1.5	equiv.),	AcOH,	r.	t.,	13	%	2;	b)	substituted	acetophenone	(1	equiv.),	NaOH	(0.75-2	equiv.),	EtOH,	r.	t.;	c)	SnCl2	(5-
10	equiv.)	or	cat.	Pd-C	(10	%),	H2,	AcOH,	r.	t.,	38	%	3,	31	%	4,	26	%	5,	37	%	6,	18	%	7,	69	%	8;	d)	HNO3	(1.25	equiv.),	Ac2O,	r.	
t.,	 11	%	10;	 e)	 SeO2	 (2	equiv.),	 neat,	 150	 °C,	 28	%	11	 (45	%	based	on	 conversion);	 f)	 4-hydroxyacetophenone	 (1	equiv.),	
NaOH	(2	equiv),	EtOH,	r.	t.;	g)	Fe	(10	equiv.),	AcOH,	reflux,	56	%	12;	h)	acetophenone	(1	equiv.),	NaOH	(0.75	equiv),	EtOH,	r.	
t.;	i)	Pd-C	(10	%),	H2,	AcOH,	r.	t.,	12	%	14	(yields	of	chalcones	indicated	for	two-steps,	“one-pot”	reactions).	See	Electronic	
Supporting	Information	for	all	synthetic	procedures.	(b)	Semi-quantitative	emission	spectra	of	3-aminobenzochalcones	3-8	
(50	µM)	in	toluene	at	20	°C.	
	
3-Aminobenzochalcones	were	indeed	fluorescent	compounds,	in	agreement	with	our	design	of	this	novel	fluorophore.	
However,	while	electro-withdrawing	acetophenyle	rings	were	expected	to	yield	the	most	fluorescent	compounds	(Scheme	
1),	 the	strongest	 fluorescence	was	associated	 to	 the	electrodonating	4’-hydroxy	group	 (cpd	8),	while	a	4’-trifluoromethyl	
group	 (cpd	3)	 induced	 a	much	weaker	 fluorescence	 (Fig.	 2b).	 The	 spectral	 properties	 of	 these	 fluorophores	 are	 given	 in	
Table	S1	in	the	Electronic	Supplementary	Information	and	depicted	in	Fig.	3.	3-Aminobenzochalcones	optimally	display	high	
Stokes	shifts	predicting	an	absence	of	internal	quenching,	with	emission	in	the	green-yellow	region	of	the	visible	spectrum	
in	 toluene.	 As	 anticipated	 from	 Fig.	 2,	 4’-hydroxy-3-aminobenzochalcone	 8	 (HAB),	 with	 a	 54.0	 %	 quantum	 yield,	 was	
significantly	more	fluorescent	than	its	non-substituted	congener	6.	This	relation	is	validated	by	the	further	weaker	quantum	
yield	of	38.2	%	of	the	p-trifluoromethyle	derivative	3.Importantly,	the	favourable	influence	of	a	strongly	electrodonating	A	
ring	called	for	revision	of	fluorophore	representation	in	the	chalcone	series,	with	permanent	enolization	of	the	carbonyle	
occurring	 in	an	extended	conjugation	pattern	similarly	to	the	prototypical	 fluorescein	or	rhodamine	fluorophores	(Fig.	3).	
Further,	HAB	was	far	more	fluorescent	than	its	5-amino	regioisomer	12	with	a	ca.	20-fold	higher	quantum	yield.		
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Figure	 3	 Structure-fluorescence	 relationships	 and	 logD7.4	 values	 at	 20	 °C	 in	 the	 3-aminobenzochalcone,	 5-
aminobenzochalcone	and	2-aminochalcone	series	(colours	indicative	of	fluorescence	emissions).	
	
This	enormous	difference	 in	quantum	yield	between	HAB	and	12	cannot	be	explained	solely	by	conjugation	patterns:	
HAB	features	rotational	hindrance	of	the	3-amino	group	(having	peri	relationships	with	H-2),	a	phenomenon	absent	in	the	
5-amino	 regioisomer	12.25,	 26	As	a	 result,	HAB	 should	be	 less	 susceptible	 to	non-radiative	desexcitation	 than	12,	 thereby	
favouring	fluorescence	transitions.	Comparing	the	isoelectronic	compounds	3-aminobenzochalcone	6	and	2-aminochalcone	
14	 showed	 as	 expected	 that	 the	 substitution	 of	 the	 (B)	 phenyle	 group	 for	 a	 naphthyle	 in	 6	 resulted	 in	 much	 stronger	
fluorescent	emission.	Compound	6	thus	possesses	a	quantum	yield	over	eight-fold	higher	than	14,	the	latter	also	displaying	
cyan	emission	and	a	smaller	Stokes	shift.	Noteworthy	for	future	biological	studies,	the	quantum	yield	of	54.0	%	for	the	most	
fluorescent	aminobenzochalcone	HAB	 is	higher	 than	 those	of	dansylamides	 (e.	g.,	DPP)27	and	 indocyanines	 (e.	g.,	 ICG),28	
prototypical	fluorescent	probes	for	live-cell	and	live-animal	imaging,	respectively,	and	is	also,	to	our	knowledge,	the	highest	
described	to	date	in	the	chalcone	series	(see	Table	S1	in	the	Electronic	Supplementary	Information).		
	
Solvatochromic	behavior.	HAB	and	its	non-substituted	analogue	6	exhibited	pronounced	solvatochromism	(Δmaxλem	~	140	
nm),	being	virtually	non-fluorescent	in	water,	biological	buffers	and	alcohols,	moderately	emissive	in	polar	aprotic	solvents	
(e.	g.,	ethyle	acetate)	and	strongly	fluorescent	in	non-polar	solvents	(e.	g.,	toluene),	with	the	exception	of	alcanes.		While	6	
was	significantly	fluorescent	in	n-hexane	and	n-octane,	its	4’-hydroxy	derivative	HAB	proved	undetectable	in	these	solvents,	
and	showed	only	weak	fluorescence	in	n-alkanols	used	to	model	biological	lipids	(e.	g.,	n-heptanol)	(Fig.	4a,b).	Although	the	
lack	of	 fluorescence	of	HAB	 in	biological	buffers	may	be	perceived	as	a	 limitation	for	 imaging	studies,	 it	must	be	realized	
that	the	binding	of	HAB	 to	amphipathic	affinity	sites	of	protein	targets	should	result	 in	a	4-500	fold	fluorescence	turn-on	
(FTO)	according	to	Fig.	4b.10	 	As	a	proof-of-principle,	bovine	serum	albumin	 (BSA)	quenched	HAB	weak	blue	 fluorescence	
(λex	=	360	nm,	λem	=	445	nm)	in	a	dose-response	manner	while	inducing	the	formation	of	a	strongly	yellow-emitting	HAB-
protein	 fluorescent	 complex	 (λex	 =	 420	 nm,	 λem	 =	 578	 nm)	 (Fig.	 4e-f).	 A	 FTO	 of	 21.5	 (excitation	 at	 420	 nm,	 at	 BSA	
concentration	 of	 10	 mg/ml)	 was	 observed	 upon	 binding	 of	 HAB	 to	 the	 protein	 (Fig.	 4f),	 associated	 to	 an	 important	
bathochromic	shift	of	its	fluorescence	spectrum	(Δλex	=	60	nm,	Δλem	=	133	nm)	which	was	similar	to	that	obtained	in	the	
polar	aprotic	solvent	DMF	(Fig.	4d,f).	This	behaviour	is	opposite	to	that	of	chalcones	binding	the	physiological	sites	of	BSA	
and	displaying	slight	ipsochromic	shifts	and	quenching	effects	indicative	of	an	apolar	environment,18	suggesting	that		HAB	
binds	 non-conventional	 BSA	 sites.	 Overall,	 HAB	 should	 be	 featured	 with	 high	 signal-to-noise	 ratio	 and	 elevated	
pharmacological	sensitivity,	low	or	negligible	predicted	fluorescence	in	compartments	such	as	the	extracellular	medium,	the	
cytosol	 and	 the	 membranes	 under	 free	 form,	 and	 high	 fluorescence	 when	 target-bound	 (“in-target”	 fluorogenesis).	
Moreover,	 its	 absence	 of	 fluorescence	 in	 water	 or	 buffers	 has	 the	 potential	 to	 greatly	 simplify	 and	 time-optimize	 the	
staining	protocols,	with	suppression	of	tedious	washing	steps	and	diffusion	liabilities	following	dye	administration.	
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Figure	 4	 HAB	 shows	 strong	 solvatochromism	 and	 protein-dependent	 fluorogenesis.	 (a,b)	 Semi-quantitative	 emission	
spectra	of	3-aminobenzochalcone	6	(Fig.	4a)	and	HAB	(Fig.	4b)	in	various	solvents	(50	µM).	A	:	H2O	;	B	:	TRIS	buffer	10	mM,	
pH	7,	NaCl	 100	mM,	MgCl2	 5	mM;	C	:	 AcOH	;	D	:	DMSO	;	E	:	MeCN	;	H:	 CHCl3;	 I:	 AcOEt;	 J	:	 1,4-dioxane	;	K	:	 benzene	;	 L	:	
toluene.	 Dissimilar	 solvent	 lettering	 between	 the	 figures	 are	 F:	 n-hexane;	G:	 n-octane	 (Fig.	 3a)	 and	 F:	 n-butanol;	G:	 n-
heptanol	 (Fig.	 3b).	 (c,d)	Normalized	 excitation	 spectra	 (purple	 lines)	 and	 fluorescence	 emission	 spectra	 (blue	 or	 orange	
lines)	of	HAB	(50	µM)	in	TRIS	buffer	pH	7.0	(TRIS.HCl	10	mM,	NaCl	100	mM,	MgCl2	5	mM)	(c)	or	DMF	(d).	(e)	Fluorescence	
emission	spectra	of	HAB	(50	µM)	titrated	by	BSA	(0	to	1	mg/mL)	in	TRIS	buffer	with	an	excitation	wavelength	of	360	nm.	(f)	
Fluorescence	emission	spectra	of	HAB	(50	µM)	titrated	by	BSA	(1	to	10	mg/mL)	in	TRIS	buffer	with	an	excitation	wavelength	
of	420	nm.	Arrows	indicate	the	decrease	or	increase	in	fluorescence	following	the	addition	of	BSA.	UVA-irradiated	cuvettes	
in	the	corresponding	conditions	are	shown	as	insets	in	(c),	(d)	and	(f).	
	
Cytopermeability	evaluation.	Lipophilicity	is	a	key	physicochemical	parameter	affecting	cellular	penetration	and	subcellular	
distribution	 in	vitro,	as	well	as	pharmacokinetics	 in	vivo.29	We	measured	the	partition	coefficients	of	key	benzochalcones	
compared	 to	 reference	 chalcones	 using	 n-octanol	 and	 pH	 7.4	 phosphate	 buffered	 saline	 (PBS),	 as	 to	 draw	 structure-
cytopermeability	relationships	in	this	novel	series	(Fig.	3).	As	expected,	the	favorable	influence	of	a	naphthyle	vs	a	phenyl	
ring	regarding	fluorescence	was	also	exerted	 in	terms	of	 lipophilicity,	as	3-aminobenzochalcone	6	and	HAB	possessed	log	
D7.4	 values	 significantly	 higher	 than	 that	 of	 mere	 2-aminochalcone	 14.	 In	 particular,	 6	 was	 almost	 three	 times	 more	
lipophilic	than	its	exact	2-aminochalcone	congener	14.	On	the	other	hand,	the	presence	of	a	4’-hydroxy	group	on	HAB	made	
it	2-fold	more	hydrophilic	than	its	4’-deshydroxy	congener	6.	Further,	HAB	was	three	to	eleven	times	more	lipophilic	than	3-
nitrochalcone	15	and	natural	flavokawain	A	16	chosen	as	representative	biologically-active	chalcones30,	31	(Fig.	3).	Overall,	
the	neat	amphipathicity	 (log	D7.4	between	1.5	and	2.5),	neutrality	as	well	 as	 small	molecular	weight	 (289.3	Da)	of	HAB
32	
predict	an	optimal	histopermeability	for	this	compound,	which	thus	could	behave	as	a	fast-acting	fluorescent	probe	in	vivo.	
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HAB	labels	specific	cells	 in	 live	zebrafish	embryos	and	swimming	larvae.	HAB,	the	most	fluorescent,	solvatochromic	and	
histopermeable	 derivative	 obtained,	 was	 tested	 in	 representative	 transparent	 animal	 models.	We	 chose	 the	 nematode	
Caenorhabditis	elegans	and	the	zebrafish	Danio	rerio	 to	study	the	cell	and	organelle	distribution	of	HAB	 in	complete	 live	
systems	 and	 assess	 its	 biological	 specificity.	HAB	 could	 not	 be	microscopically	 visualized	 in	 C.	 elegans	 due	 to	 excessive	
autofluorescence	 of	 the	 nematode	 (data	 not	 shown).	 On	 the	 other	 hand,	 HAB	 displayed	 a	 unique	 labeling	 pattern	 in	
zebrafish	that	deserved	 in-depth	 investigation.	When	HAB	was	 incubated	at	10	µM	for	60	min	on	 live	zebrafish	embryos	
and	swimming	larvae	ranging	from	24	hours	post-fertilization	(hpf)	to	72	hpf,	fluorescence	emission	was	detected	mainly	in	
the	 550-650	 nm	window	 following	 excitation	 at	 488	 nm,	 indicative	 of	 a	 non-aqueous	 	 environment	 (see	 Fig.	 4b	 for	 the	
solvatochromic	properties	of	HAB,	and	Fig.	S2	 in	 the	Electronic	Supplementary	 Information	 for	 the	emission	spectrum	of	
HAB	 in	vivo).	Since	the	fluo-labeling	was	maximal	 in	the	yellow-orange	region	of	the	visible	spectrum,	this	suggested	that	
HAB	bound	to	specific	proteins	with	strong	target-induced	bathochromic	fluorogenesis	and	FTOs	(Fig.	4e-h).	This	 labeling	
displayed	a	neat	pattern	of	punctuated	areas	that	first	appeared	by	32	hpf	in	the	ventral	tail	of	the	embryo	(Fig.	5a,e).	The	
number	 and	 intensity	 of	 HAB	 fluorescent	 spots	 progressively	 increased	 at	 48	 hpf	 and	 72	 hpf	 following	 the	 known	
deployment	of	macrophages	 and	neutrophils	 during	 zebrafish	development,4,	 5	 suggesting	 that	 these	 cell	 types	 could	be	
targeted	by	HAB.	The	shape	and	size	of	the	fluorescent	spots	within	the	caudal	region	of	the	specimens	suggested	labeling	
of	some	subcellular	compartment	rather	than	whole	cells.5		Noteworthy,	the	already	autofluorescent	pigment	cells	present	
in	72	hpf	larva	underwent	a	significant	increase	of	fluorescence	in	presence	of	HAB	(Fig.	4c,d)	suggesting	that	the	probe	also	
accumulated	within	these	cells	due	to	their	high	content	in	aromatic	pigments	(i.	e.,	pteridine	and	guanine	derivatives).33,	34	
	
	
	
Figure	5	HAB	labels	specific	cells	in	live	zebrafish	from	32	hpf.	Confocal	fluorescence	imaging	of	HAB	 labeling	(10	µM)	in	
live	wild-type	zebrafish	embryos	(32	and	48	hpf)	and	swimming	larvae	(72	hpf)	following	excitation	at	488	nm	and	detection	
in	 the	 550-650	 nm	 range.	 The	 yellow-orange	 color	 is	 indicative	 of	 the	 fluorescence	 seen	with	 the	 naked	 eye.	Maximum	
intensity	Z-projection	images	(2	µm	serial	optical	sections)	are	shown.	Arrows	point	to	HAB	 label;	asterisks	mark	pigment	
cells.	A,	artery;	N,	notochord;	V,	vein.		
	
HAB	 labeling	 is	 reversible.	HAB	 labeling	was	 found	 to	be	 fairly	photostable	 in	 the	 conditions	used	 so	 far,	with	ca.	 50	%	
fluorescence	 lost	 after	 30	 min	 of	 continuous	 illumination	 at	 488	 nm.	 However,	 since	 the	 embryos	 and	 larvae	 were	
systematically	washed	and	mounted	in	HAB-free	agarose	for	live	imaging,	the	diffusion	of	HAB	outside	of	its	binding	sites	
might	be	responsible	for	the	 loss	of	 labeling	overtime.	To	discriminate	between	free	diffusion	and	photobleaching	as	the	
two	possible	causes	for	signal	loss,	we	performed	time-lapse	imaging	experiments	in	wich	either	of	these	two	phenomena	
was	kept	to	a	minimum.	To	test	the	free	diffusion	hypothesis,	72	hpf	zebrafish	larvae	were	treated	with	10	µM	HAB	for	1	hr,	
washed	and	mounted	in	tracer-free	mounting	medium,	then	imaged	over	time	with	short	exposure-acquisition	pulses	every	
10	 min.	 Under	 these	 conditions	 of	 lower	 illumination	 hence	 limited	 photobleaching,	 the	 detection	 of	 HAB-labeled	
structures	was	no	longer	possible	after	ca.	1	hr,	with	again	ca.	50	%	of	fluorescence	lost	after	30	min	exposure	(see	Figure	
S3	in	the	Electronic	Supplementary	Information).	To	test	the	photobleaching	hypothesis,	we	treated	the	72	hpf	larvae	with	
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10	µM	HAB	for	1	hr	and	mounted	them	in	agarose	and	tricaine	containing	10	µM	HAB.	We	then	imaged	the	zebrafish	larva	
embedded	 in	HAB	10µM	over	 time	under	continuous	 illumination	 (indicate	 time	 lapse	here)	by	 the	488	nm	 laser.	Under	
these	conditions	of	maximum	photobleaching	and	abolished	 free	diffusion,	HAB	 labeling	proved	highly	photostable,	as	 it	
could	be	detected	for	up	to	15	hrs	of	time-lapse	imaging	(see	Video	S4	in	the	Electronic	Supplementary	Information).	This	
observation	indicates	that	HAB	bound	in	vivo	continually	exchanges	with	free	non-fluorescent	HAB,	at	a	rate	faster	than	the	
photobleaching	 of	 the	 bound	HAB	 during	 continuous	 488	 nm	 laser	 illumination.	 This	 remarkable	 feature	makes	HAB	 an	
ideal	 live	stain	 for	both	 long-term	and	high	 temporal	 resolution	confocal	 imaging	of	neutrophil	granules	 in	 the	zebrafish.	
These	 conditions	 of	 constant	 equilibrium	 by	 continuous	 contact,	made	 possible	 by	 the	 absence	 of	HAB	 fluorescence	 in	
aqueous	media,	constitute	optimal	settings	for	HAB	 labeling	on	the	zebrafish	model	and	are	particularly	suitable	for	long-
term	experiments.		
	
HAB	labels	neutrophil	granules	in	live	zebrafish	larvae.	To	identify	the	cell	type(s)	labeled	by	HAB,	that	according	to	their	
localization	 and	 developmental	 timing	 of	 detection	 could	 be	 the	 first	 leukocytes	 of	 the	 zebrafish	 embryo	 and	 larva	
(macrophages	and/or	neutrophils),	we	stained	zebrafish	 transgenic	72	hpf	 larvae	harbouring	 fluorescent	macrophages	or	
neutrophils35-37with	 HAB.	 Upon	 treatment	 with	 10	 µM	 HAB	 of	 Tg(Mfap4:mCherry-F)	 larvae	 possessing	 red-fluorescent	
macrophages	expressing	mCherry,	we	found	that	the	probe	did	not	co-localize	with	the	red-fluorescent	macrophages	(Fig.	
6a-d).	Due	to	the	wide	emission	range	of	the	mCherry	protein	(560-760	nm),	that	overlapped	with	that	of	the	yellow-green	
emitting	 HAB,	 mCherry	 was	 imaged	 following	 excitation	 at	 552	 nm	 and	 collecting	 only	 the	 “far	 red”	 portion	 of	 its	
fluorescence	emission	(660-750	nm),	and	HAB	was	excited	at	448	nm	and	collecting	the	550	-	650	nm	range	of	its	emission	
spectrum.	 Upon	 treatment	 with	 10µM	HAB	 of	 Tg(mpx:GAL4/UAS-E1b:nsfB-mCherry)	 larvae	 with	 neutrophils	 expressing	
mCherry	 in	their	cytoplasm	and	using	the	same	HAB/mCherry	acquisition	parameters	as	above,	we	could	show	that	HAB	
perfectly	 colocalized	with	all	 neutrophils	of	 the	 imaged	ventral	 tail	 region,	 labeling	a	 specific	 compartment	within	 them.	
(Fig.	6e-h).	Using	GFP-labeled	neutrophils	(Tg(mpx:GFP)	strain),	and	sequentially	detecting	GFP	emission	in	the	500-520	nm	
range	and	HAB	using	the	“red”	portion	of	 its	emission	spectrum	(>	600	nm)	by	exciting	both	fluorophores	by	the	448nm	
laser	(Fig.	6i-l)	we	confirmed	that	HAB	targeted	a	neutrophil	specific	compartment.	Not	only	did	HAB	stained	all	neutrophils	
of	 the	 ventral	 tail	 region	 of	 72	 hpf	 larvae,	 where	 they	 are	 known	 to	 be	 particularly	 abundant2,	 4,	 37,	 but	 HAB-labeled	
neutrophils	could	also	found	in	the	eye,	ear	and	yolk	of	72	hpf	larvae	(data	not	shown),	indicating	that	HAB	labels	the	entire	
neutrophil	 population	 in	 vivo.	 Collectively,	 these	 observations	 demonstrated	 that	 zebrafish	 neutrophils	 are	 the	 cell	 type	
selectively	 targeted	 by	HAB,	where	 it	 specifically	 labels	 a	 compartment	within	 these	 cells.	 To	 identify	 the	 compartment	
targeted	by	HAB	within	neutrophils,	we	performed	high-resolution	confocal	 imaging	of	HAB-labeled	cells	 in	72	hpf	 larvae	
harbouring	 red	 neutrophils	 combining	 the	 fluorescence	 detection	 of	HAB	 and	 mCherry	 with	 DIC	 microscopy.	HAB	 was	
found	to	co-localize	with	neutrophil	granules,	which	are	easily	recognizable	in	transmitted	light	/	DIC	imaging5,	38	for	they	
are	refractile	and	constantly	moving	in	the	cytoplasm	(Fig.	6m-p).	This	colocalization	was	unambiguously	demonstrated	by	
the	perfect	overlap	of	fluorescence	HAB	signals	and	DIC	images	during	time-lapse	acquisitions	of	live	patrolling	neutrophils	
(see	 high-resolution	 Videos	 S5	 and	 S6	 in	 the	 Electronic	 Supplementary	 Information).	 Similar	 to	 their	 mammalian	
counterpart,	 the	granules	of	 zebrafish	neutrophils	 contain	myeloperoxidase.2,	 38,	 39	 The	diazo	dye	Sudan	Black	B	 (SB)	 is	 a	
classical	 lipid	 stain	 that	 specifically	 labels	 the	 myeloperoxidase-positive	 granules	 of	 zebrafish	 neutrophils,5,	 40	 as	 also	
observed	 in	human	neutrophils.41,	 42	The	first	SB-stained	granules	are	detected	by	33-35	hpf	 in	zebrafish	embryos,	within	
the	 first,	 still	 immature	 embryonic	 neutrophils;	 this	 staining	 then	 increases	 in	 number	 and	 intensity,	 revealing	 the	
deployment	of	neutrophils	during	zebrafish	development.5	To	check	that	HAB	was	targeting	the	same	granule	population	as	
SB	 in	 neutrophils,	we	 tried	 to	 combine	 the	 two	 dyes.	We	 first	 tested	 if	 the	HAB	 label	was	 compatible	with	 the	 fixation	
protocol	classically	used	to	fix	zebrafish	embryos	and	larvae,	but	failed	to	detect	HAB	labeling	in	the	larva	post-fixation	for	
two	hours	at	room	temperature	with	either	1	or	4	%	formaldehyde,	or	when	performing	HAB	labeling	before	the	fixation.	
This	could	be	due	to	the	loss	of	HAB	pharmacology	in	fixed	samples,	or	to	the	reaction	of	HAB	with	formaldehyde,	leading	
to	 fluorophore	destruction:	eventhough	HAB	 is	both	a	very	weak	organic	base	 (predicted	pKa	value	of	3.97	 for	 its	amino	
tautomers,	see	Figure	S7	 in	the	Electronic	Supplementary	 Information)	and	a	weak	nucleophile,	possessing	the	electronic	
features	of	a	vinylogous	amide,	this	possibility	cannot	be	ruled	out	 in	absence	of	dedicated	study.	 In	any	case,	 it	was	not	
possible	to	combine	the	SB	staining	with	the	HAB	labeling.		
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Figure	6	HAB	labels	zebrafish	neutrophil	granules.	(a-l)	Confocal	fluorescence	imaging	of	HAB	(10	µM)	in	live	transgenic	72	
hpf	zebrafish	larvae	following	excitation	at	448	nm	under	equilibrium	conditions.	Detection	parameters	were	as	follow:	for	
HAB	/	mCherry:	λEX	448	nm,	λEM	550-650	nm,	mCherry:	λEX	552	nm,	λEM	660-750	nm	using	sequential	modes	of	acquisition.	
For	GFP	/	HAB:	GFP	λEX	448	nm,	λEM	500-520	nm,	HAB:	λEX	448	nm,	λEM	550-650	nm	using	sequential	modes	of	acquisition.	
Maximum	 intensity	Z-projection	 images	 (2	µm	serial	optical	 sections)	are	 shown.	 (m-p)	High-resolution	DIC	and	confocal	
fluorescence	imaging	of	HAB	(10	µM)	in	live	72	hpf	zebrafish	larva	harbouring	red	neutrophils.	Arrows	point	to	HAB-labeled	
granules	according	to	the	DIC	images	in	neutrophils.	A	single	0.4	µm	optical	section	is	shown.	Boxes	in	Fig.	6c,g,k	indicate	
the	regions	magnified	in	the	insets	(Fig.	6d,h,l	respectively).	Abbreviations	used:	A	(aorta);	N	(notochord);	V	(vein);	asterisk	
=	nucleus.	See	Electronic	Supplementary	Information	for	Videos	S5	and	S6	related	to	Fig.	6m-p.	
	
HAB	reveals	the	behavior	of	neutrophil	granules	during	phagocytosis	in	live	zebrafish	larva.	To	circumvent	this	technical	
limitation,	 we	 sought	 indirect	 evidence	 for	 the	 identity	 of	 neutrophil	 granules	 as	 the	 targets	 of	HAB.	 One	 of	 the	most	
important	functions	of	neutrophils	is	to	eliminate	invading	microorganisms.	Neutrophils	are	highly	phagocytic	cells,	able	to	
engulf	 and	 kill	microbes	with	 the	 arsenal	 of	microbicidal	 compounds	 stored	 in	 their	 granules.	 Once	 they	 have	 engulfed	
microbes,	neutrophils	release	the	granule	content	(e.g.,	myeloperoxidase-produced	hypochlorous	acid	and	proteases)	into	
the	 phagosome.	We	 have	 shown	 that	 in	 vivo,	 zebrafish	 neutrophils	 degranulate	 into	 the	 phagosome	 following	microbe	
phagocytosis	and	that	the	myeloperoxidase	activity	initially	contained	in	the	granules	often	relocalises	to	the	phagosome,	
while	 the	 SB	 staining	 correlatively	 disappears.43	 	 These	 steps	 have	 been	 advantageously	 reproduced	 with	 opsonized	
zymosan	 particles	 in	 cultured	 mammalian	 neutrophils,	 to	 show	 that	 neutrophil	 granules	 are	 recruited	 to	 the	 nascent	
phagosome	in	which	they	deliver	their	content	by	exocytosis.8,	44	To	determine	whether	HAB	would	allow	the	visualization	
of	 neutrophil	 granule	 dynamics	 during	 phagocytosis	 in	 vivo,	 we	 vitally	 stained	 a	 zebrafish	 larva	 with	 HAB,	 then	
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subcutaneously	 injected	 red-fluorescent	Cy5-zymosan,	 and	 immediately	monitored	 the	 interaction	between	HAB-labeled	
neutrophil	 granules	 and	 zymosan	 particles	 by	 high	 resolution	 confocal	 imaging	 (Fig.	 7).	 We	 found	 that	 upon	 zymosan	
phagocytosis,	HAB-labeled	granules	are	massively	recruited	to	the	particle-containing	phagosomes	(Fig.	7a,b,d	and	related	
Video	 S8	 in	 ESI),	 similar	 to	 the	myeloperoxidase	 containing,	 SB-labeled	 granules	which	 relocalised	 around	 the	 zymosan-
containing	phagosome	in	the	fixed	larva	(Fig.	7c).	These	observations	strongly	suggest	that	the	myeloperoxidase-containing	
granules	are	the	targets	of	HAB	in	vivo.	They	also	represent,	to	our	knowledge,	the	first	documentation	of	the	dynamics	of	
neutrophil	degranulation	upon	phagocytosis	in	an	entire	live	organism.	
	
	
Figure	7	HAB	reveals	the	dynamics	of	neutrophil	granules	upon	phagocytosis	of	zymosan	particles	in	live	zebrafish.	(a,b)	
Confocal	 live	imaging	of	HAB-labeled	neutrophil	granules	upon	phagocytosis	of	subcutaneously-injected	zymosan	in	a	live	
72	 hpf	 zebrafish	 larva	 under	 equilibrium	 conditions.	HAB	 is	 recruited	 to	 the	 forming	 phagosomes	 (arrows).	 Inset:	HAB	
labeling	 of	 resting	 neutrophil.	 (c)	 Sudan	 Black	 (SB)	 staining	 of	 myeloperoxidase-containing	 neutrophil	 granules	 showing	
granule	recruitment	to	the	phagosome	upon	zymosan	phagocytosis	 in	fixed	zebrafish	 larva.	 Inset:	SB	staining	of	a	resting	
neutrophil;	 A	 single	 1µm	 optical	 section	 is	 shown.	 (d)	 Frames	 extracted	 from	 an	 in	 vivo	 time-lapse	 confocal	 imaging	
sequence	(time	step	=	1	min).	Arrows	point	to	HAB-labeled	neutrophil	granules	that	are	recruited	to	the	nascent	zymosan	
containing	 phagosome.	 Three	 neutrophils	 (pointed	 with	 number	 1	 to	 3)	 were	 tracked	 during	 the	 time	 lapse	 sequence.	
Maximum	 intensity	 Z-projection	 (1	 µm	 serial	 optical	 sections).	 See	 Electronic	 Supplementary	 Information	 for	 Video	 S8	
related	to	Fig.	7d.	
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HAB	does	not	target	neutrophil	myeloperoxidase,	and	the	staining	of	neutrophil	granules	by	HAB	is	not	a	general	feature	
of	 chalcones.	 To	 tentatively	 identify	 the	 specific	 protein	 target	 of	HAB	 in	 the	 neutrophil	 granules,	 we	 performed	HAB	
labeling	 in	myeloperoxidase	 knock-out	 zebrafish	 larvae	 (“spotless”	 strain)	 under	 equilibrium	 conditions.45	While	mutant	
larvae	 showed	 the	 expected	 absence	 of	 SB	 staining,	 they	 nevertheless	 still	 exhibited	 a	 fluorescent	 labeling	 with	 HAB	
qualitatively	 and	 quantitatively	 indistinguishable	 from	 wild-type	 larvae	 (Fig.	 8a-c).	 This	 result	 shows	 that	 the	
myeloperoxidase	 abundant	 in	 neutrophil	 granules	 is	 not	 the	 biochemical	 target	 of	HAB.	 We	 also	 tested	 a	 selection	 of	
biologically-active	chalcones	as	possible	HAB	competitors,	based	on	their	known	or	putative	action	on	neutrophils	such	as	
inhibition	of	myeloperoxidase	activity	or	 repressing	effects	on	pro-inflammatory	mediators	 such	as	NF-κB,	TNF-α,	 COX-2	
and	various	 interleukines.46-48	 The	natural	 chalcones	 flavokawain	A	16	 and	 cardamonin	17	are	potent	 anti-inflammatory,	
proapoptotic	 and	 antitumour	 agents	 in	 mouse	 models,	 due	 to	 their	 ability	 to	 block	 NF-κB	 signaling.31,	 49-51	 Synthetic	
chalcone	 18	 is	 an	 inhibitor	 of	 chemokine	 CXCL12	 that	 blocks	 its	 binding	 to	 several	 chemokine	 receptors,	 preventing	
eosinophil	infiltration	in	an	asthma	mouse	model.52	3-nitrochalcone	15	possesses	pronounced	antinociceptive	properties	in	
mice	 that	 are	 anti-inflammatory	 in	 origin.53	 Last,	 4-methylchalcone	 19	 was	 selected	 due	 to	 its	 homology	 with	 mere	
(unsubstituted)	 chalcone,	 reported	 to	 exert	 anti-myeloperoxidase	 and	 anti-migratory	 effects	 on	 zebrafish	 neutrophils.46	
Larvae	were	first	incubated	with	the	competitors	alone	at	100	µM	for	1	hr	to	assess	their	toxicity,	as	well	as	possible	basal	
fluorescence	 in	 the	 zebrafish.	 Under	 these	 conditions,	 all	 specimens	 remain	 alive	 with	 no	 apparent	 toxicity	 from	 the	
chalcones.	Moreover,	using	the	same	detection	settings	than	for	HAB	at	10	µM	(λEX	488	nm,	λEM	550-650	nm),	none	of	the	
competitors	showed	fluorescence	and	their	 labeling	was	undistinguishable	from	that	of	the	negative	control	DMSO	(data	
not	 shown),	 except	 for	 chalcone	 18	 (see	 below	 and	 Fig.	 S9	 in	 the	 Electronic	 Supplementary	 Information).	When	 these	
various	potential	competitors	were	co-incubated	at	100	µM	with	HAB	at	10	µM	in	the	same	conditions,	we	could	observe	
no	extinction	or	diminution	of	HAB	 fluorescence	 in	 vivo	with	any	of	 these	 competitors	 relative	 to	 the	 control	 (Fig.	 8e-j).	
Moreover,	fluorimetric	association	experiments	in	TRIS	buffer	or	DMF	(where	HAB	shows	the	same	type	of	yellow-orange	
fluorescence	 as	 in	 neutrophil	 granules,	 see	 Fig.	 4d)	 demonstrated	 that	 none	 of	 these	 chalcones,	 when	 incubated	 in	
presence	 of	 HAB	 at	 the	 same	 10:1	 stoichiometry,	 induced	 any	 significant	 qualitative	 or	 quantitative	 change	 in	 HAB	
fluorescence.	The	only	exception	was	chalcone	18	which	caused	strong	emission	quenching	in	both	media	(data	not	shown),	
a	feature	not	at	play	in	zebrafish	larvae	in	vivo	(Fig.	8g).	The	binding	of	HAB	to	neutrophil	granules	thus	appears	to	be	the	
result	of	the	probe’s	precise	physicochemical	signature,	rather	than	a	general	feature	of	chalcones.	
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Figure	 8	 HAB	 does	 not	 target	 zebrafish	 neutrophil	 myeloperoxidase,	 and	 its	 binding	 to	 neutrophil	 granules	 is	 not	 a	
general	feature	of	chalcones.	(a,c)	Merged	confocal	fluorescence	and	bright-field	imaging	of	HAB	(10	µM)	in	live	wild-type	
(a)	 or	 “Spotless”	 (NL	 144_01	 mutant:	 null	mpx	 allele)	 (c)	 72	 hpf	 zebrafish	 larvae	 following	 excitation	 at	 488	 nm	 and	
detection	 in	 the	 550-650	 nm	 range	 under	 equilibrium	 conditions.	 (b,d)	 SB	 staining	 of	 myeloperoxidase-containing	
neutrophil	granules	in	bright-field	imaging.	(e-j)	Merged	confocal	fluorescence	and	bright-field	imaging	of	HAB	(10	µM)	in	
live	wild-type	72	hpf	zebrafish	larvae	co-treated	with	chalcones	15,	16	(flavokawain	A),	17	(cardamonin),	18	or	19	(100	µM)	
following	excitation	at	488	nm	and	detection	in	the	550-650	nm	range	under	diffusion	conditions.	The	yellow-orange	color	
is	 indicative	of	the	fluorescence	seen	with	the	naked	eye.	Single	2	µm	optical	sections	are	shown.	 	Abbreviations	used:	A	
(aorta);	N	(notochord);	UGO	(urogenital	opening);	V	(vein).	
	
During	the	course	of	this	competition	study,	we	discovered	that	4-hydroxy-3-methoxy-4‘-chlorochalcone	(Cpd.	18)	at	100	
µM	 was	 responsible	 for	 unusual	 fluorescence	 in	 presence	 of	 HAB	 (Fig.	 8g),	 and	 deserved	 further	 investigation.	 When	
incubated	alone	at	the	same	concentration	on	72	hpf	larvae	and	excited	at	488	nm,	chalcone	18	exhibited	a	green-yellow	
fluorescence	that	illuminated	the	anatomy	of	the	specimens.	Indeed,	confocal	imaging	showed	that	the	fluorescence	of	18	
delineated	the	trunk	neuromasts,	somite	muscle	fibers	and	boundaries,	blood	vessels,	notochord,	spinal	cord,	spinal	canal	
and	caudal	hematopoietic	tissue	(Fig.	S9	 in	the	Electronic	Supplementary	 Information).	Detailed	examination	revealed	no	
detectable	 intracellular	 staining,	 but	 interstitial	 histological	 labeling.	 This	 behavior	 is	 reminiscent	 of	 that	 of	 BODIPY-
ceramide,	a	fluorescent	dye	previously	used	at	similarly	high	concentration	as	a	histological	counterstain	for	the	confocal	
imaging	of	live	zebrafish	embryos.54,	55	The	fact	that	chalcone	18	was	not	cytopermeable	even	at	high	concentration	further	
validates	 the	 global	 design	 of	HAB,	 a	 benzochalcone	 congener,	 as	 a	 histo-	 and	 cytopermeable	 tracer	 for	 in	 vivo	 studies.	
Interestingly,	chalcone	18	was	recently	evaluated	in	the	zebrafish	model	as	an	inhibitor	of	the	chemokine	CXCL12a,	for	its	
activity	against	 the	collective	migration	of	cells	of	 the	posterior	 lateral	 line	primordium.	At	10	µM,	18	 showed	moderate	
biological	 effects	 and	 was	 not	 fluorescently	 detected	 by	 GFP	 filters.56	 The	 complete	 study	 of	 chalcone	 18	 regarding	
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fluorescence	detection	threshold,	photostability,	phenotypic	effects	and	long-term	toxicity	is	currently	underway,	in	order	
to	validate	this	compound	as	a	novel	anatomical	interstitial	live	stain	in	the	zebrafish	model.	
	
HAB	 labels	 granules	 in	 live	 human	 primary	 neutrophils.	 In	 order	 to	 validate	HAB	 as	 a	 specific	 vital	 stain	 of	 neutrophil	
granules	 not	 only	 in	 fish	 but	 also	 in	 mammals,	 and	 to	 assess	 its	 relevance	 for	 human	 studies,	 we	 attempted	 the	 HAB	
labeling	 of	 live	 primary	 human	 neutrophils	 freshly	 isolated	 from	 total	 blood.	 Human	 neutrophils	 exist	 under	 two	
morphologically-	 and	 phenotypically-distinct	 types	 depending	 on	 their	 state	 of	 activation.	 Whereas	 non-activated	
neutrophils	consist	 in	round-shaped	non-adhering	circulating	cells,	activated	neutrophils	are	polyhedral	cells	expressing	a	
number	of	cytoadhesins	and	adhering	to	endothelium	walls,	glass	or	plastic	surfaces.57,	58	When	stained	with	10	µM	HAB,	
non-activated	neutrophils	exhibited	 intense	but	diffuse	 fluorescent	 labeling,	presumably	due	to	the	difficulty	of	 resolving	
subcellular	 structures	 when	 imaging	 non-adherent	 cells	 (Fig.	 9a-c).	 An	 equally	 intense	 labeling	 of	 cells	 at	 the	 level	 of	
subcellular	 granular	 structures	 was	 detected	 in	 the	 same	 conditions	 in	 activated	 neutrophils,	 consistent	 with	 the	
morphology	 and	 distribution	 of	 human	 neutrophil	 granules,59,	 60	 in	 addition	 to	 a	 strong	 perinuclear	 staining	 possibly	
corresponding	to	the	nuclear	membrane	(Fig.	9d-f	and	S10	in	the	Electronic	Supplementary	Information	).	To	address	the	
human	blood	cell	selectivity	issue,	we	assessed	HAB	labeling	on	other	freshly-isolated	cell	populations	from	whole	human	
blood	(peripheral	blood	mononuclear	cells,	PBMC)	 in	the	same	conditions	than	those	used	to	 image	purified	neutrophils.	
HAB	 was	 found	 to	 exhibit	 an	 impressive	 selectivity	 for	 neutrophils	 over	 lymphocytes,	 monocytes,	 erythrocytes	 and	
thrombocytes	 (platelets),	 that	were	 all	weakly	 to	 faintly	 labeled	 (Fig	 9g-i).	 This	 selectivity	 seems	 to	 be	 the	 result	 of	 the	
accumulation	 of	HAB	 in	 neutrophil	 granules,	 consistent	with	 the	 complete	 cell	 and	 organelle	 specificity	 observed	 in	 the	
zebrafish	model	 in	 vivo.	 Although	 these	 results	 deserve	 further	 investigation	 regarding	 the	 subset	of	 granules	 labeled	 in	
human	neutrophils,59	they	constitute	a	strong	presumption	that	the	specific	labeling	of	neutrophil	granules	by	HAB	 in	the	
zebrafish	model	is	also	relevant	in	mammalian	systems.	
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Figure	 9	 HAB	 selectively	 labels	 live	 human	 primary	 neutrophils	 over	 other	 blood	 cell	 types.	 (a-c)	 and	 (d-f):	 Confocal	
fluorescence	and	DIC	imaging	of	HAB	(10	µM)	in	live	human	neutrophils	following	excitation	at	448	nm	and	detection	in	the	
550-650	nm	range.	Single	0.4	µm	optical	sections	are	shown.	(a-c)	show	resting,	non-activated,	non-adherent	neutrophils.	
(d-f)	show	activated,	adherent	neutrophils:	note	HAB	staining	of	neutrophils	granules;	(g-i):	Confocal	fluorescence	and	DIC	
imaging	of	HAB	(10	µM)	in	live	human	lymphocytes	(lc),	erythrocytes	(ec),	monocytes	(mc)	and	thrombocytes	(tc)	using	the	
same	settings	than	in	(a-c)	and	(d-f).	Single	0.4	µm	optical	sections	are	shown.	The	yellow-orange	color	is	indicative	of	the	
fluorescence	seen	with	the	naked	eye.	Asterisk	=	nucleus.  
	
Discussion	
	A	 novel	 3-aminobenzochalcone,	 HAB,	 was	 rationally	 designed,	 synthesized	 and	 validated	 as	 a	 histopermeable	 and	
fluorogenic	vital	stain	for	in	vivo	biological	studies.	Photophysically,	HAB	has	elevated	Stokes	shift,	the	highest	fluorescence	
quantum	 yield	 described	 to	 date	 in	 this	 series,	 elevated	 signal-to-noise	 ratio	 upon	 protein	 binding,	 and	 unprecedented	
photostability.	 This	 also	 chemically	 very	 stable	 tracer	possesses	 the	minimal	 architecture	 to	be	 strongly	 fluorescent,	 and	
stains	neutrophils	in	zebrafish	embryo	and	larva	with	extraordinary	specificity,	with	no	labeling	of	other,	even	related,	cell	
types	 (e.	 g.,	macrophages).	 Subcellularly,	HAB	 proved	 specific	of	 zebrafish	neutrophil	 granules,	with	no	 staining	of	other	
organelles	or	compartments.	This	behavior	was	rationalized	as	target-induced	bathochromic	fluorogenesis	based	on	various	
chemical	and	biochemical	model	 systems.	Neutrophil	 labeling	was	 independent	of	 the	 state	of	 cell	 activation,	 since	HAB	
stained	the	granules	of	both	resting	and	phagocytically-active	neutrophils	with	equal	intensity	and	specificity.	HAB	labeling	
in	 the	 zebrafish	 followed	 the	 deployment	 of	 neutrophil	 from	 32	 hpf	 embryo	 to	 72	 hpf	 swimming	 larva	 and	 was	 even	
visualised	 in	 neutrophil	 granules	 in	 6	 day-old	 larva	 with	 similar	 sensitivity	 despite	 the	 increase	 in	 tissue	 density	 and	
thickness	(see	Fig.	S11	in	the	Electronic	Supplementary	Information).	Due	to	its	absence	of	toxicity	up	to	48	hrs	incubation	
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and	 outstanding	 photostability,	 HAB	 is	 ideal	 for	 the	 long-term,	 high	 temporal	 resolution	 live	 imaging	 of	 developing	
zebrafish,	 with	 the	 potential	 of	 dynamic	 monitoring	 of	 the	 neutrophil	 granules	 in	 virtually	 any	 physiological	 or	
physiopathological	context.	To	our	knowledge,	no	other	related	tracer	is	endowed	with	such	precious	characteristics.	Last,	
HAB	 intensely	 labeled	 freshly	 purified	 neutrophils	 from	human	 blood	 at	 the	 level	 of	 granular	 structures	 consistent	with	
neutrophil	 granules.	 Fluorescent	 dyes	 for	 neutrophil	 granules	 are	 limited,	 including	 quinacrine	 (QA),8	 LysoTrackerRed®	
(LTR),9	dihydrorhodamine	(DHR)	123,9	and	rhodamine-thiolactones	(RTLs),61	which	are	non-specific	by	essence.	QA	and	LTR	
as	weak	bases	constitute	general	acidotropic	stains,	sequestrated	under	their	protonated	form	in	various	low	pH	organelles	
and	 vesicles	 (e.	 g.,	 lysosomes,62-64	 apoptotic	 vesicles,65	 mast	 cell	 granules66,	 67),	 to	 which	 mammalian	 basophil	 and	
neutrophil	secreted	granules	also	belong.68,	69	DHR	123	and	RTLs	are	part	of	ROS-activated	profluorophores	used	to	detect	
hydrogen	peroxide/peroxynitrite	and	hypochlorous	acid,	 respectively,	 in	activated	neutrophils	as	well	 as	 in	various	other	
cell	systems	and	organelles.61,	70-72	A	comparative	analysis	of	the	various	existing	tracers	of	neutrophil	granules	is	provided	
in	Table	1.	 In	marked	contrast,	the	unique	staining	of	 live	zebrafish	neutrophil	granules	by	HAB	over	other	cell	types	and	
acidic	 compartments	 in	 the	 whole	 organism,	 together	 with	HAB	 very	 weak	 basicity	 (about	 105-fold	 lower	 than	 that	 of	
acidotropic	 amines63	 with	 predicted	 pKa	 value	 of	 3.97	 for	 	 the	 amino	 tautomers,	 see	 Figure	 S7	 in	 the	 Electronic	
Supplementary	 Information),	 supports	 a	 specific	 target-induced	 labeling	 of	 neutrophil	 granules	 by	 HAB.	 Although	 we	
showed	that	the	myeloperoxidase	present	in	the	granules	as	is	not	involved	in	their	specific	staining	by	HAB,	these	granules	
also	 contain	 abundant	 neutral	 serine	 proteases	 (e.	 g.,	 elastase,	 proteinase	 3,	 cathepsin	 G),59	 which	 constitute	 putative	
biochemical	 targets	 for	HAB	based	on	their	 reactivity	 towards	 reversible	electrophilic	 inhibitors.73,	 74	 In	 this	context,	HAB	
has	an	immediate	surrogate	for	proteomic	interrogation	under	the	form	of	a	photoalkylative	azido	analogue	(Fig.	1)	easily	
accessible	 through	 Sandmeyer-type	 modification	 of	 the	 aromatic	 amino	 group.22	 The	 covalent	 photolabeling	 of	 live	
zebrafish	 larvae	 or	 isolated	human	neutrophils	with	 a	 fluorogenic	 3-azido-4‘-hydroxybenzochalcone,	 FACS	purification	of	
labeled	cells	followed	by	Western	Blot	identification	of	the	covalently-stained	molecular	target(s)	of	HAB,	therefore	seems	
within	 reach.	 Overall,	 due	 to	 its	 optimal	 photophysical	 and	 physicochemical	 properties	 and	 unprecedented	 biological	
specificity,	HAB	 constitutes	 a	 valuable	 small-molecule	 addition	 to	 the	 fluorescent	 proteins	 toolbox	 used	 in	 the	 zebrafish	
model,	which	 it	 functionally	 and	 spectrally	 complements,	 and	 appears	 suitable	 for	 functional	 studies	 in	 live	mammalian	
neutrophils.	 HAB	 therefore	 holds	 great	 promise	 as	 a	 vital	 stain	 to	 monitor	 the	 dynamics	 and	 behaviour	 of	 neutrophil	
granules	in	various	aspects	of	the	neutrophil	function	in	the	context	of	a	live	organism,	with	potential	relevance	to	human	
physiology	and	physiopathology.	
	
Table	1	Functional	comparison	of	HAB	with	existing	tracers	of	neutrophil	granules	
TRACER	
SPECIFICITY	
FOR	
NEUTROPHIL	
GRANULES	
HISTOPERMEABILITY	
FOR	LIVE	ANIMAL	
IMAGING	
PHOTOSTABILITY	 FLUOROGENESIS	 REF.	
Quinacrine	
No	(acidotropic	
stain,	DNA	
stain)	
Yes	 Yes	 No	
65,	75-
77	
LysoTrackers	
No	(acidotropic	
stains)	
Yes	 No	 No	
9,	65,	
77-79	
Acridine	orange	
No	(acidotropic	
stain,	DNA/RNA	
stain)	
Yes	 Yes	 No	
65,	80-
83	
Dihydrorhodamine	123	
No	(ROS/RNS-
dependent	-	
also	labels	
mitochondria)	
No	(in	vitro	only)	 No	 Yes	(ROS-activated)	 9,	84-87	
Rhodamine-
thiolactones	
No	(ROS-
dependent)	
Yes	 Yes	 Yes	(ROS-reactive)	 61,	88	
Sudan	Black	B	
Yes	
(lipids/MPO-
dependent)	
No	(FA	fixation	in	
vivo)	
NA	
(colorimetric	stain)	
NA	
(colorimetric	stain)	
5,	42,	
89	
Luminol	
No	(ROS-
dependent,	
MPO-amplified)		
No	(in	vitro	only)	
NA	
(chemoluminescent	
stain)	
NA	
(chemoluminescent	
stain)	
90	
Tyramide-FITC	/	Cy3	
Yes	(MPO-
reactive)	
No	(FA	fixation	in	
vivo)	
No	(FITC	conjugate)	
No	 5,	91	
Yes	(Cy3	conjugate)	
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MUB40	/	RI-MUB40-Cy5	
Yes	(lactoferrin	
ligands)	
No	(peptides,	FA	
fixation	in	vitro,	in	
vivo)	
Yes	 No	 60	
NE680	
Yes	(elastase	
substrate)	
No	(peptide,	MeOH	
fixation	ex	vivo,	
intranasal	instillation	
in	mouse)	
Yes	
Yes	(enzyme-
activated)	
92	
Elastase,	cathepsin	G,	
proteinases	3	and	4	
substrates	
Yes	(enzyme	
substrates)	
No	(peptides,	FA	
fixation	in	vitro)	
Yes	
Yes	(enzyme-
activated)	
93	
HAB	
Yes	(pH,	ROS,	
MPO-
independent	
fluorescence)	
Yes	(amphipathic	
small-molecule,	
logD7.4	=	2.21)	
Yes	(>	15	hrs	under	
continuous	488	nm	
irradiation)	
Yes	(target	protein-
induced	FTO)	
Our	
study	
Abreviations:	FA,	formaldehyde;	FITC,	fluorescein	isothiocyanate;	FTO,	Fluorescence	Turn-On;	MeOH,	methanol;	MPO,	
myeloperoxidase;	NA,	non-applicable;	RNS,	reactive	nitrogen	species;	ROS,	reactive	oxygen	species.	
Methods	
Compound	 synthesis,	 structural	 characterization	 and	 pKa	 prediction.	 Detailed	 synthetic	 procedures	 and	 analytical	
identification	for	compounds	2-8,	10-12	and	14,	as	well	as	pKa	prediction	for	HAB,	can	be	found	in	the	Electronic	Supporting	
Information.	
	
Zebrafish.	Transgenic	and	mutant	stocks	of	zebrafish	were	raised	and	staged	according	to	Westerfield.94	AB	wild-type	fish	
and	transgenic	 lines	Tg(mpx:GFP)i114,	Tg(mpx:GAL4.VP16)i22,	Tg(Mfap4:mCherry-F)	and	Tg(UAS-E1b:nfsB.mCherry)c264	were	
used.35-37	Embryos	were	reared	at	28	°C	or	24	°C	according	to	the	desired	speed	of	development.	All	timings	in	the	text	refer	
to	 the	 developmental	 stage	 at	 the	 reference	 temperature	 of	 28.5	 °C.94	 Embryo	 and	 larvae	were	 anesthetized	with	 200	
μg/ml	tricaine	(Sigma-Aldrich)	during	live	in	vivo	imaging.		
	
HAB	labeling	of	live	zebrafish	embryo	and	larva.	
Equilibrium	 protocol	 (Fig.	 6,	 9,	 S10	 and	 S11,	 Video	 S5,	 S6	 and	 S7):	72	 hpf	 or	 6	 dpf	 zebrafish	 larvae,	 either	wild-type	 AB	
specimens	 or	 transgenic	 specimens,	were	 placed	 in	 individual	wells	 (24-well	 culture	 plates;	 10	 embryos	 or	 larvae/well),	
incubated	with	HAB	(10	µM	in	Volvic	water	from	10	mM	stock	solutions	in	DMSO)	at	room	temperature	for	1	hr	in	the	dark,	
anaesthetized	in	buffered	tricaine	(Sigma)	containing	HAB	 (10	µM)	then	mounted	in	35	mm	glass-bottom	dishes	(Inagaki-
Iwaki)	in	1	%	low-melting-point	agarose	containing	HAB		(10	µM)	to	ensure	equilibrium	conditions.	The	immobilized	larvae	
were	then	covered	with	2	ml	Volvic	water	containing	tricaine	and	HAB	(10	µM)	as	described	previously.43	Negative	controls	
consisted	of	Volvic	water	containing	0.1	%	DMSO.	For	wild-type	AB	specimens	as	well	as	transgenic	specimens,	HAB	was	
incubated	for	1	hr.	
Diffusion	 protocol	 (Fig.	 5,	 7,	 8,	 Fig.	 S4,	 S9,	 Video	 S8):	 	Wild-type	 AB	 zebrafish	 embryos	 and	 swimming	 larvae	 (24	 hpf	 to	
72hpf)	were	placed	 in	 individual	wells	 (24-well	culture	plates;	10	embryos	or	 larvae/well),	 incubated	with	HAB	 (10	µM	in	
Volvic	water	 from	10	mM	stock	 solutions	 in	DMSO)	at	 room	temperature	 for	1	hr	 in	 the	dark,	washed,	anaesthetized	 in	
HAB-free	 buffered	 tricaine	 (Sigma)	 then	 mounted	 in	 35	 mm	 glass-bottom	 dishes	 (Inagaki-Iwaki)	 in	 HAB-free	 1	 %	 low-
melting-point	agarose.	The	 immobilized	larvae	were	then	covered	with	2	ml	Volvic	water	containing	tricaine	as	described	
previously.43	 Negative	 controls	 consisted	 of	 Volvic	 water	 containing	 0.1	 %	 DMSO.	 Practically,	 homogenous	 aqueous	
solutions	of	HAB	were	obtained	by	adding	the	drop	of	stock	DMSO	solutions	on	the	inner	wall	of	a	plastic	tube	containing	
Volvic	water	at	room	temperature	(20-23	°C),	and	vortexing	without	interruption	for	20	s.	
	
Sudan	Black	staining	(Fig.	7).	Embryos	were	fixed	with	4%	methanol-free	formaldehyde	(Poly-sciences,	Warrington,	PA)	in	
phosphate-buffered	 saline	 (PBS)	 for	 2	 hours	 at	 room	 temperature,	 rinsed	 in	 PBS,	 incubated	 in	 Sudan	 Black	 (SB;	 Sigma-
Aldrich)	for	20	minutes,	washed	extensively	in	70%	ethanol	in	water,	then	progressively	rehydrated	in	0.1%	Tween	20	in	PBS	
as	previously	decribed.5	
	
Zymosan	microinjection	in	zebrafish	larvae	(Fig.	7).	Zebrafish	larvae	(72	hpf)	were	anaesthetized	by	immersion	in	buffered	
tricaine	immediately	after	the	HAB	labeling.	They	were	injected	with	1	nl	of	0.4	x	108/ml	zymosan-Cy5	particles	suspension	
using	 pulled	 borosilicate	 glass	 microcapillary	 (GC100F-15	 Harvard	 apparatus)	 pipettes	 under	 a	 stereomicroscope	 (Stemi	
2000,	 Carl	 Zeiss,	 Germany)	 with	 a	 mechanical	 micromanipulator	 (M-152;	 Narishige),	 and	 a	 Picospritzer	 III	 pneumatic	
microinjector	 (Parker	Hannifin)	 set	at	a	pressure	of	20	psi	and	an	 injection	 time	of	20	msec	 (subcutaneous	 injections)	as	
previously	described.43	
	
Competition	 experiments	 (Fig.	 8).	 72	 hpf	 wild-type	 AB	 zebrafish	 larvae	 were	 placed	 into	 individual	 wells	 as	 previously	
described	and	co-incubated	 for	1	hr	at	 room	temperature	with	HAB	 (10	µM	from	a	10	mM	stock	solution	 in	DMSO)	and	
each	 competitor	 (100	µM	 from	 a	 10	mM	 stock	 solution	 in	 DMSO)	 in	 Volvic	 water	 in	 the	 dark	 as	 previously	 described.	
Negative	 controls	 consisted	 of	 Volvic	 water	 containing	 1.1	 %	 DMSO.	 In	 this	 case,	 specimens	 were	 rapidly	 rinsed,	
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anaesthetized	and	mounted	 in	HAB-free	media	for	biological	 imaging.	Practically,	homogenous	aqueous	solutions	of	HAB	
+/-	 competitors	were	obtained	by	adding	 the	drop	of	 stock	DMSO	solutions	on	 the	 inner	wall	 of	 a	plastic	 tube	 containg	
Volvic	water	at	room	temperature	(20-23	°C),	and	vortexing	without	interruption	for	20	s.	
	
HAB	labeling	of	 live	human	neutrophils	 (Fig.	9	and	S10).	Peripheral	human	blood	was	collected	from	healthy	patients	at	
the	 ICAReB	 service	of	 the	Pasteur	 Institute	 (authorization	DC	No.	2008-68).	All	 donors	 gave	written	 informed	consent	 in	
accordance	with	the	Declaration	of	Helsinki	principles.	Blood	was	collected	from	the	antecubital	vein	into	tubes	containing	
sodium	 citrate	 (3.8	 %	 final)	 as	 anticoagulant.	 Human	 polymorphonuclear	 neutrophils	 were	 purified	 as	 described	
previously.95	Briefly,	plasma	was	removed	by	centrifugation	(450	g,	15	min),	and	blood	cells	were	resuspended	in	0.9	%	NaCl	
solution	 supplemented	 with	 0.72	 %	 Dextran.	 After	 red	 blood	 cells	 sedimentation,	 white	 blood	 cells	 were	 pelleted	 and	
further	separated	on	a	two	layers	Percoll	(GE	Healthcare)	gradient	(51-42	%)	by	centrifugation	(240	g,	20	min).	Peripheral	
Blood	Mononuclear	Cells	(PBMC)	(top	layer)	were	isolated	from	polymorphonuclear	neutrophils	(bottom	layer).	Red	blood	
cells	 were	 removed	 from	 the	 latter	 fraction	 using	 CD235a	 (glycophorin)	 microbeads	 (Miltenyi	 Biotec).	 Purified	
polymorphonuclear	neutrophils	were	resuspended	in	the	autologous	plasma	until	experimental	use.	For	HAB	labeling,	they	
were	immediately	put	in	RPMI	10	mM	Hepes	at	2	x	106	cells/ml.	1	ml	of	neutrophil	suspension	was	distributed	in	35	mm	
glass-bottom	 dishes	 and	 incubated	 at	 room	 temperature	 for	 20	 min	 for	 neutrophils	 adhesion.	 The	 medium	 was	 then	
replaced	by	the	HAB	staining	solution	(at	1,	5	or	10	µM)	in	RPMI	10	mM	Hepes;	after	5-15	min	at	room	temperature,	HAB-
labeled	neutrophils	were	observed	with	a	SP8	Leica	confocal	microscope,	using	a	63x	water	 immersion	objective.	The	10	
µM	HAB	concentration	gave	the	best	results.	
	
Live	 imaging,	 image	 processing	 and	 analysis.	 Confocal	 microscopy	 to	 detect	HAB	 single	 labeling	 in	 wild-type	 zebrafish	
embryos	and	larvae	was	performed	at	23-26	°C	using	a	Leica	SPE	inverted	microscope	and	a	16X	oil	immersion	objective	(PL	
FLUOTAR	16X/0.50	IMM).	HAB	was	excited	with	a	488	nm	laser	and	the	fluorescence	emission	collected	within	the	550-650	
nm	range	unless	otherwise	indicated.	A	Leica	SP8	confocal	microscope	with	a	20X	oil	immersion	objective	(HC	PL	APO	CS2	
20X/0.75	 IMM)	was	used	to	 live	 image	transgenic	 larvae	 for	colocalization	studies	and	wt	 larvae	 for	competition	studies.	
Regarding	HAB/mCherry	acquisition,	 the	 following	settings	were	applied:	HAB	 (excitation	448	nm;	emission	550-650	nm)	
and	mCherry	(excitation	552	nm;	emission	660-750	nm)	using	a	sequential	acquisition	mode.	For	GFP/HAB	acquisition	the	
following	settings	were	applied:	GFP	(excitation	448	nm;	emission	500-520	nm)	and	HAB	(excitation	448	nm;	emission	>	600	
nm).	 A	 40X	 water	 immersion	 objective	 (HC	 PL	 APO	 CS2	 40X	 /	 1.1	 water)	 was	 used	 also	 with	 the	 SP8	 LEICA	 confocal	
microscope,	 to	 document	 at	 high	 resolution	 HAB	 labeling	 in	 neutrophils.	 For	 HAB-zymosan	 acquisition,	 the	 following	
settings	were	applied:	HAB	(excitation	488	nm;	emission	491-601	nm)	and	Cy5-zymosan	(excitation	638	nm;	emission	683-
795	 nm).	 A	 63x	 water	 immersion	 objective	 (HC	 PL	 APO	 CS2	 63X	 /	 1.2	 water)	 was	 used	 to	 image	 HAB	 in	 live	 human	
neutrophils,	following	excitation	at	448	nm	and	collecting	the	fluorescence	emission	in	the	550-650	nm	range.	The	3D	or	4D	
files	generated	by	the	confocal	acquisitions	were	processed	using	the	LAS-AF	Leica	software.	Acquired	Z-stacks	(2	µm	serial	
optical	 sections	 for	 images	 taken	using	16X	and	20X	objectives)	were	projected	using	maximum	 intensity	projection	and	
exported	as	AVI	or	TIFF	files.	Z	stacks	acquired	with	the	40X	or	63X	objectives	(0.4	µm	to	1µm	serial	optical	sections)	were	
exported	as	AVI	file.	Frames	were	captured	from	the	AVI	files	and	handled	with	Powerpoint	software	to	mount	figures.		
	
References	
	
1.	 S.	Masud,	V.	Torraca	and	A.	H.	Meijer,	Curr	Top	Dev	Biol,	2017,	124,	277-329.	
2.	 G.	J.	Lieschke,	A.	C.	Oates,	M.	O.	Crowhurst,	A.	C.	Ward	and	J.	E.	Layton,	Blood,	2001,	98,	3087-3096.	
3.	 D.	Traver,	P.	Herbomel,	E.	E.	Patton,	R.	D.	Murphey,	J.	A.	Yoder,	G.	W.	Litman,	A.	Catic,	C.	T.	Amemiya,	L.	I.	
Zon	and	N.	S.	Trede,	Advances	in	Immunology,	Vol	81,	2003,	81,	253-330.	
4.	 P.	Herbomel,	B.	Thisse	and	C.	Thisse,	Development,	1999,	126,	3735-3745.	
5.	 D.	Le	Guyader,	M.	 J.	Redd,	E.	Colucci-Guyon,	E.	Murayama,	K.	Kissa,	V.	Briolat,	E.	Mordelet,	A.	Zapata,	H.	
Shinomiya	and	P.	Herbomel,	Blood,	2008,	111,	132-141.	
6.	 K.	M.	Henry,	C.	A.	Loynes,	M.	K.	B.	Whyte	and	S.	A.	Renshaw,	Journal	of	Leukocyte	Biology,	2013,	94,	633-
642.	
7.	 E.	A.	Harvie	and	A.	Huttenlocher,	Journal	of	Leukocyte	Biology,	2015,	98,	523-537.	
8.	 E.	Suzaki,	H.	Kobayashi,	Y.	Kodama,	T.	Masujima	and	S.	Terakawa,	Cell	Motility	and	the	Cytoskeleton,	1997,	
38,	215-228.	
9.	 C.	F.	Bassoe,	N.	Y.	Li,	K.	Ragheb,	G.	Lawler,	J.	Sturgis	and	J.	P.	Robinson,	Cytometry	Part	B-Clinical	Cytometry,	
2003,	51B,	21-29.	
10.	R.	Duval	and	C.	Duplais,	Nat	Prod	Rep,	2017,	34,	161-193.	
11.	N.	DiCesare	and	J.	R.	Lakowicz,	Tetrahedron	Letters,	2002,	43,	2615-2618.	
12.	J.	Prabhu,	K.	Velmurugan	and	R.	Nandhakumar,	Spectrochim	Acta	A	Mol	Biomol	Spectrosc,	2015,	144,	23-28.	
13.	C.	G.	Niu,	A.	L.	Guan,	G.	M.	Zeng,	Y.	G.	Liu	and	Z.	W.	Li,	Analytica	Chimica	Acta,	2006,	577,	264-270.	
14.	S.	C.	Lee,	N.	Y.	Kang,	S.	J.	Park,	S.	W.	Yun,	Y.	Chandran	and	Y.	T.	Chang,	Chem	Commun	(Camb),	2012,	48,	
6681-6683.	
15.	M.	Tomasch,	J.	S.	Schwed,	L.	Weizel	and	H.	Stark,	Front	Syst	Neurosci,	2012,	6,	14.	
17	
	
16.	B.	Zhou,	P.	Jiang,	J.	Lu	and	C.	Xing,	Arch	Pharm	(Weinheim),	2016,	349,	539-552.	
17.	T.	Fuchigami,	Y.	Yamashita,	M.	Haratake,	M.	Ono,	S.	Yoshida	and	M.	Nakayama,	Bioorg	Med	Chem,	2014,	22,	
2622-2628.	
18.	H.	G.	O.	Alvim,	E.	L.	Fagg,	A.	L.	de	Oliveira,	H.	C.	B.	de	Oliveira,	S.	M.	Freitas,	M.	A.	E.	Xavier,	T.	A.	Soares,	A.	
F.	Gomes,	 F.	C.	Gozzo,	W.	A.	 Silva	and	B.	A.	D.	Neto,	Organic	&	Biomolecular	Chemistry,	 2013,	11,	 4764-
4777.	
19.	A.	Bessette,	T.	Auvray,	D.	Desilets	and	G.	S.	Hanan,	Dalton	Transactions,	2016,	45,	7589-7604.	
20.	P.	M.	Alexander,	H,	Nature,	1962,	194,	2.	
21.	D.	Kulms	and	T.	Schwarz,	Skin	Pharmacology	and	Applied	Skin	Physiology,	2002,	15,	342-347.	
22.	S.	 J.	 Lord,	 H.	 L.	 Lee,	 R.	 Samuel,	 R.	Weber,	 N.	 Liu,	 N.	 R.	 Conley,	M.	 A.	 Thompson,	 R.	 J.	 Twieg	 and	W.	 E.	
Moerner,	J	Phys	Chem	B,	2010,	114,	14157-14167.	
23.	S.	D.	Barker,	K.	Wilson	and	R.	K.	Norris,	Australian	Journal	of	Chemistry,	1995,	48,	1969-1979.	
24.	P.	G.	E.	Alcorn,	Wells,	P.	R.,	Australian	Journal	of	Chemistry,	1965,	18,	1377-1389.	
25.	V.	Balasubramaniyan,	Chemical	Reviews,	1966,	66,	567-+.	
26.	D.	Skalamera,	L.	P.	Cao,	L.	Isaacs,	R.	Glaser	and	K.	Mlinaric-Majerski,	Tetrahedron,	2016,	72,	1541-1546.	
27.	A.	Niemann,	J.	Baltes	and	H.	P.	Elsasser,	Journal	of	Histochemistry	&	Cytochemistry,	2001,	49,	177-185.	
28.	X.	 J.	Yang,	C.	M.	Shi,	R.	Tong,	W.	P.	Qian,	H.	E.	Zhau,	R.	X.	Wang,	G.	D.	Zhu,	J.	 J.	Cheng,	V.	W.	Yang,	T.	M.	
Cheng,	M.	Henary,	L.	Strekowski	and	L.	W.	K.	Chung,	Clinical	Cancer	Research,	2010,	16,	2833-2844.	
29.	R.	A.	Duval,	R.	L.	Allmon	and	J.	R.	Lever,	J	Med	Chem,	2007,	50,	2144-2156.	
30.	P.	 Boeck,	 C.	 A.	 B.	 Falcao,	 P.	 C.	 Leal,	 R.	 A.	 Yunes,	 V.	 Cechinel,	 E.	 C.	 Torres-Santos	 and	B.	 Rossi-Bergmann,	
Bioorganic	&	Medicinal	Chemistry,	2006,	14,	1538-1545.	
31.	X.	L.	Zi	and	A.	R.	Simoneau,	Cancer	Research,	2005,	65,	3479-3486.	
32.	M.	J.	Waring,	Bioorg	Med	Chem	Lett,	2009,	19,	2844-2851.	
33.	I.	Ziegler,	T.	McDonald,	C.	Hesslinger,	I.	Pelletier	and	P.	Boyle,	J	Biol	Chem,	2000,	275,	18926-18932.	
34.	C.	W.	Higdon,	R.	D.	Mitra	and	S.	L.	Johnson,	PLoS	One,	2013,	8,	e67801.	
35.	Q.	T.	Phan,	T.	Sipka,	C.	Gonzalez,	J.	P.	Levraud,	G.	Lutfalla	and	N.	C.	Mai,	Plos	Pathog,	2018,	14.	
36.	F.	Ellett,	L.	Pase,	J.	W.	Hayman,	A.	Andrianopoulos	and	G.	J.	Lieschke,	Blood,	2011,	117,	E49-E56.	
37.	S.	A.	Renshaw,	C.	A.	Loynes,	D.	M.	I.	Trushell,	S.	Elworthy,	P.	W.	Ingham	and	M.	K.	B.	Whyte,	Blood,	2006,	
108,	3976-3978.	
38.	M.	O.	Crowhurst,	J.	E.	Layton	and	G.	J.	Lieschke,	Int	J	Dev	Biol,	2002,	46,	483-492.	
39.	C.	T.	Pham,	Nat	Rev	Immunol,	2006,	6,	541-550.	
40.	K.	Wang,	 X.	 Fang,	N.	Ma,	Q.	 Lin,	 Z.	Huang,	W.	 Liu,	M.	Xu,	 X.	 Chen,	W.	 Zhang	and	Y.	 Zhang,	Fish	 Shellfish	
Immunol,	2015,	44,	109-116.	
41.	B.	J.	Bain,	Am	J	Hematol,	2010,	85,	707.	
42.	W.	van	den	Ancker,	T.	M.	Westers,	D.	C.	de	Leeuw,	Y.	F.	van	der	Veeken,	A.	Loonen,	E.	van	Beckhoven,	G.	J.	
Ossenkoppele	and	A.	A.	van	de	Loosdrecht,	Cytometry	B	Clin	Cytom,	2013,	84,	114-118.	
43.	E.	Colucci-Guyon,	J.	Y.	Tinevez,	S.	A.	Renshaw	and	P.	Herbomel,	J	Cell	Sci,	2011,	124,	3053-3059.	
44.	E.	K.	Macrae	and	K.	B.	Pryzwansky,	Carlsberg	Research	Communications,	1984,	49,	315-322.	
45.	P.	M.	Elks,	M.	van	der	Vaart,	V.	van	Hensbergen,	E.	Schutz,	M.	J.	Redd,	E.	Murayama,	H.	P.	Spaink	and	A.	H.	
Meijer,	PLoS	One,	2014,	9,	e100928.	
46.	Y.	H.	Chen,	W.	H.	Wang,	Y.	H.	Wang,	Z.	Y.	Lin,	C.	C.	Wen	and	C.	Y.	Chern,	Molecules,	2013,	18,	2052-2060.	
47.	B.	P.	Bandgar,	S.	A.	Patil,	R.	N.	Gacche,	B.	L.	Korbad,	B.	S.	Hote,	S.	N.	Kinkar	and	S.	S.	 Jalde,	Bioorganic	&	
Medicinal	Chemistry	Letters,	2010,	20,	730-733.	
48.	J.	Z.	Wu,	J.	L.	Li,	Y.	P.	Cai,	Y.	Pan,	F.	Q.	Ye,	Y.	L.	Zhang,	Y.	J.	Zhao,	S.	L.	Yang,	X.	K.	Li	and	G.	Liang,	Journal	of	
Medicinal	Chemistry,	2011,	54,	8110-8123.	
49.	D.	J.	Kwon,	S.	M.	Ju,	G.	S.	Youn,	S.	Y.	Choi	and	J.	Park,	Food	and	Chemical	Toxicology,	2013,	58,	479-486.	
50.	N.	Wu,	J.	Liu,	X.	Z.	Zhao,	Z.	Y.	Yan,	B.	Jiang,	L.	J.	Wang,	S.	S.	Cao,	D.	Y.	Shi	and	X.	K.	Lin,	Tumor	Biology,	2015,	
36,	9667-9676.	
51.	S.	Hatziieremia,	A.	I.	Gray,	V.	A.	Ferro,	A.	Paul	and	R.	Plevin,	British	Journal	of	Pharmacology,	2006,	149,	188-
198.	
52.	M.	Hachet-Haas,	K.	Balabanian,	F.	Rohmer,	F.	Pons,	C.	Franchet,	S.	Lecat,	K.	Y.	C.	Chow,	R.	Dagher,	P.	Gizzi,	
B.	 Didier,	 B.	 Lagane,	 E.	 Kellenberger,	 D.	 Bonnet,	 F.	 Baleux,	 J.	 Haiech,	 M.	 Parmentier,	 N.	 Frossard,	 F.	
Arenzana-Seisdedos,	M.	Hibert	and	J.	L.	Galzi,	Journal	of	Biological	Chemistry,	2008,	283,	23189-23199.	
53.	F.	 de	Campos-Buzzi,	 J.	 P.	 de	Campos,	P.	 P.	 Tonini,	 R.	Correa,	R.	A.	 Yunes,	 P.	Boeck	and	V.	Cechinel-Filho,	
Archiv	Der	Pharmazie,	2006,	339,	361-365.	
54.	M.	S.	Cooper,	L.	A.	D'Amico	and	C.	A.	Henry,	Methods	Cell	Biol,	1999,	59,	179-204.	
18	
	
55.	E.	Murayama,	M.	Sarris,	M.	Redd,	D.	Le	Guyader,	C.	Vivier,	W.	Horsley,	N.	Trede	and	P.	Herbomel,	Nature	
Communications,	2015,	6.	
56.	D.	Dalle	Nogare,	K.	Somers,	S.	Rao,	M.	Matsuda,	M.	Reichman-Fried,	E.	Raz	and	A.	B.	Chitnis,	Development,	
2014,	141,	3188-3196.	
57.	N.	Yakuwa,	T.	Inoue,	T.	Watanabe,	K.	Takahashi	and	F.	Sendo,	Microbiol	Immunol,	1989,	33,	843-852.	
58.	K.	Ley,	H.	M.	Hoffman,	P.	Kubes,	M.	A.	Cassatella,	A.	Zychlinsky,	C.	C.	Hedrick	and	S.	D.	Catz,	Sci	 Immunol,	
2018,	3.	
59.	J.	L.	Eyles,	A.	W.	Roberts,	D.	Metcalf	and	I.	P.	Wicks,	Nat	Clin	Pract	Rheum,	2006,	2,	500-510.	
60.	M.	C.	Anderson,	T.	Chaze,	Y.	M.	Coic,	L.	Injarabian,	F.	Jonsson,	N.	Lombion,	D.	Selimoglu-Buet,	J.	Souphron,	
C.	Ridley,	P.	Vonaesch,	B.	Baron,	E.	T.	Arena,	 J.	Y.	Tinevez,	G.	Nigro,	K.	Nothelfer,	E.	Solary,	V.	Lapierre,	T.	
Lazure,	M.	Matondo,	D.	Thornton,	P.	 J.	Sansonetti,	F.	Baleux	and	B.	S.	Marteyn,	Cell	Chem	Biol,	2018,	25,	
483-493	e489.	
61.	X.	Chen,	K.	A.	Lee,	E.	M.	Ha,	K.	M.	Lee,	Y.	Y.	Seo,	H.	K.	Choi,	H.	N.	Kim,	M.	J.	Kim,	C.	S.	Cho,	S.	Y.	Lee,	W.	J.	Lee	
and	J.	Yoon,	Chem	Commun	(Camb),	2011,	47,	4373-4375.	
62.	D.	D.	Li,	N.	Ropert,	A.	Koulakoff,	C.	Giaume	and	M.	Oheim,	Journal	of	Neuroscience,	2008,	28,	7648-7658.	
63.	B.	Lemieux,	M.	D.	Percival	and	J.	P.	Falgueyret,	Analytical	Biochemistry,	2004,	327,	247-251.	
64.	T.	Sasaki,	S.	S.	Lian,	J.	Qi,	P.	E.	Bayliss,	C.	E.	Carr,	J.	L.	Johnson,	S.	Guha,	P.	Kobler,	S.	D.	Catz,	M.	Gill,	K.	L.	Jia,	
D.	J.	Klionsky	and	S.	Kishi,	Plos	Genetics,	2014,	10.	
65.	A.	Pierzynska-Mach,	P.	A.	Janowski	and	J.	W.	Dobrucki,	Cytometry	Part	A,	2014,	85A,	729-737.	
66.	M.	Wu,	T.	Baumgart,	S.	Hammond,	D.	Holowka	and	B.	Baird,	J	Cell	Sci,	2007,	120,	3147-3154.	
67.	H.	Y.	Chen,	D.	M.	Chiang,	Z.	J.	Lin,	C.	C.	Hsieh,	G.	C.	Yin,	I.	C.	Weng,	P.	Guttermann,	S.	Werner,	K.	Henzler,	G.	
Schneider,	L.	J.	Lai	and	F.	T.	Liu,	Sci	Rep,	2016,	6,	34879.	
68.	A.	W.	Segal,	Annual	Review	of	Immunology,	2005,	23,	197-223.	
69.	M.	A.	Kolber	and	P.	A.	Henkart,	Biochimica	Et	Biophysica	Acta,	1988,	939,	459-466.	
70.	J.	P.	Crow,	Nitric	Oxide-Biology	and	Chemistry,	1997,	1,	145-157.	
71.	Y.	Qin,	M.	Lu	and	X.	G.	Gong,	Cell	Biology	International,	2008,	32,	224-228.	
72.	L.	Yuan,	L.	Wang,	B.	K.	Agrawalla,	S.	 J.	Park,	H.	Zhu,	B.	Sivaraman,	J.	Peng,	Q.	H.	Xu	and	Y.	T.	Chang,	J	Am	
Chem	Soc,	2015,	137,	5930-5938.	
73.	A.	Budnjo,	S.	Narawane,	C.	Grauffel,	A.	S.	Schillinger,	T.	Fossen,	N.	Reuter	and	B.	E.	Haug,	J	Med	Chem,	2014,	
57,	9396-9408.	
74.	W.	C.	Groutas,	D.	Dou	and	K.	R.	Alliston,	Expert	Opin	Ther	Pat,	2011,	21,	339-354.	
75.	A.	Parks,	X.	Charest-Morin,	M.	Boivin-Welch,	J.	Bouthillier	and	F.	Marceau,	PeerJ,	2015,	3,	e1314.	
76.	A.	T.	Sumner,	Histochemistry,	1986,	84,	566-574.	
77.	P.	Huang,	Y.	Zou,	X.	Z.	Zhong,	Q.	Cao,	K.	Zhao,	M.	X.	Zhu,	R.	Murrell-Lagnado	and	X.	P.	Dong,	J	Biol	Chem,	
2014,	289,	17658-17667.	
78.	T.	Sasaki,	S.	Lian,	J.	Qi,	P.	E.	Bayliss,	C.	E.	Carr,	J.	L.	Johnson,	S.	Guha,	P.	Kobler,	S.	D.	Catz,	M.	Gill,	K.	Jia,	D.	J.	
Klionsky	and	S.	Kishi,	PLoS	Genet,	2014,	10,	e1004409.	
79.	E.	Dona,	J.	D.	Barry,	G.	Valentin,	C.	Quirin,	A.	Khmelinskii,	A.	Kunze,	S.	Durdu,	L.	R.	Newton,	A.	Fernandez-
Minan,	W.	Huber,	M.	Knop	and	D.	Gilmour,	Nature,	2013,	503,	285-289.	
80.	I.	Vermes	and	C.	Haanen,	Adv	Clin	Chem,	1994,	31,	177-246.	
81.	J.	A.	Udovich,	D.	G.	Besselsen	and	A.	F.	Gmitro,	J	Microsc,	2009,	234,	124-129.	
82.	T.	J.	van	Ham,	J.	Mapes,	D.	Kokel	and	R.	T.	Peterson,	FASEB	J,	2010,	24,	4336-4342.	
83.	B.	Tucker	and	M.	Lardelli,	Zebrafish,	2007,	4,	113-116.	
84.	M.	Poot,	Y.	Z.	Zhang,	J.	A.	Kramer,	K.	S.	Wells,	L.	J.	Jones,	D.	K.	Hanzel,	A.	G.	Lugade,	V.	L.	Singer	and	R.	P.	
Haugland,	J	Histochem	Cytochem,	1996,	44,	1363-1372.	
85.	X.	Wang,	H.	Fang,	Z.	Huang,	W.	Shang,	T.	Hou,	A.	Cheng	and	H.	Cheng,	J	Mol	Med	(Berl),	2013,	91,	917-927.	
86.	I.	D.	Trayner,	A.	P.	Rayner,	G.	E.	Freeman	and	F.	Farzaneh,	J	Immunol	Methods,	1995,	186,	275-284.	
87.	J.	P.	Crow,	Nitric	Oxide,	1997,	1,	145-157.	
88.	Y.	Koide,	Y.	Urano,	K.	Hanaoka,	T.	Terai	and	T.	Nagano,	J	Am	Chem	Soc,	2011,	133,	5680-5682.	
89.	B.	J.	Bain,	in	Dacie	and	Lewis	Practical	Haematology	(Twelfth	Edition),	ed.	B.	J.	Bain,	Bates,	I.,	Laffan,	M.	A.,	
Elsevier,	2017.	
90.	S.	Bedouhene,	F.	Moulti-Mati,	M.	Hurtado-Nedelec,	P.	M.	Dang	and	J.	El-Benna,	Am	J	Blood	Res,	2017,	7,	41-
48.	
91.	G.	Lauter,	I.	Soll	and	G.	Hauptmann,	Methods	Mol	Biol,	2014,	1082,	175-185.	
92.	S.	Kossodo,	J.	Zhang,	K.	Groves,	G.	J.	Cuneo,	E.	Handy,	J.	Morin,	J.	Delaney,	W.	Yared,	M.	Rajopadhye	and	J.	
D.	Peterson,	Int	J	Mol	Imaging,	2011,	2011,	581406.	
19	
	
93.	P.	Kasperkiewicz,	Y.	Altman,	M.	D'Angelo,	G.	S.	Salvesen	and	M.	Drag,	 J	Am	Chem	Soc,	2017,	139,	10115-
10125.	
94.	M.	Westerfield,	The	Zebrafish	Book.	A	Guide	for	the	Laboratory	Use	of	Zebrafish	(Danio	rerio),	University	of	
Oregon	Press,	1995.	
95.	V.	Monceaux,	C.	Chiche-Lapierre,	C.	Chaput,	V.	Witko-Sarsat,	M.	C.	Prevost,	C.	T.	Taylor,	M.	N.	Ungeheuer,	P.	
J.	Sansonetti	and	B.	S.	Marteyn,	Blood,	2016,	128,	993-1002.	
	Acknowledgements		
The	authors	wish	to	acknowledge	the	following	contributors:	Dr.	L.	Bianchi	and	Prof.	G.	Petrillo	for	the	generous	gift	of	a	
reference	of	compound	10;	Dr.	P.	Leal	for	the	gift	of	xanthoxyline;	Prof.	S.	Renshaw	and	Prof.	G.	Lutfalla	for	providing	with	
the	zebrafish	transgenic	Tg(mpx:GAL4.VP16)i22	and	Tg(mfap4:mCherryF)		lines,	respectively;	Dr.	F.	Niedergang	for	the	gift	of	
cy5-zymosan;	 T.	M.	 R.	Gianeti	 and	Dr.	 A.	Maciuk	 for	 their	 practical	 help	 regarding	NIR	 fluorescence	 and	HRMS	 analysis,	
respectively;	A.	Blin	for	taking	pictures	of	UVA-irradiated	cuvettes	in	Fig.	4;	Dr.	N.	Bizat	for	preliminary	labelling	experiments	
in	C.	elegans;	V.	Briolat,	Y.	Rolin	and	N.	Aimar	for	fish	husbandry,	as	well	as	L.	Boucontet	for	helping	with	zebrafish	embryo	
preparation;	 Dr.	 M.	 Anderson	 for	 the	 preparation	 of	 isolated	 human	 neutrophils;	 Dr.	 A.	 Cras	 for	 fruitful	 discussions	
regarding	the	biology	of	human	blood	cells.	R.	Duval	gratefully	acknowledges	Prof.	R.	J.	Nunes,	Prof.	B.	Rossi-Bergmann	and	
Prof.	 N.	 Leulliot	 for	 permitting	 certain	 experiments	 to	 be	 conducted	 in	 their	 laboratories.	 The	 Conselho	 Nacional	 de	
Desenvolvimento	Científico	e	Tecnológico	(CNPq)	and	the	Pasteur	Institute	are	acknowledged	for	financial	support,	as	well	
as	J.	Moreira	for	helping	with	the	production	of	the	grant	scientific	proposal	in	Portuguese.	 
 
Notes	and	references	 
The	abreviations	used	 in	 the	present	article	as	well	as	 in	 the	ESI	are:	AcOEt,	ethyle	acetate;	AcOH,	acetic	acid;	BF,	bright	
field;	 CC,	 column	 chromatography;	 CHCl3,	 chloroform;	 DHR,	 dihydrorhodamine;	 DIC,	 Differential	 Interference	 Contrast;	
DMF,	dimethylformamide;	DMSO,	dimethylsulfoxide;	DPP,	N-dansyl-N’-phenylpiperazine;	FACS,	fluorescence-activated	cell	
sorting;	F,	fluorescence	quantum	yield;	HAB,	4’-hydroxy-3-aminobenzochalcone;	HRMS,	high-resolution	mass	spectra;	ICG,	
indocyanine	green;	LTR,	LysoTrackerRed;	MeCN,	acetonitrile;	MPO,	myeloperoxidase;	PBMC,	peripheral	blood	mononuclear	
cells;	ROS,	reactive	oxygen	species;	RTL,	rhodamine-thiolactone;	QA,	quinacrine;	SB,	Sudan	Black.	 
 
Keywords:	benzochalcone	•	histopermeability	•	fluorogenesis	•	zebrafish	•	neutrophils	•	granules	•	live	imaging	 
 
Author	contributions	
E.	C.-G.	designed,	performed	and	analysed	the	HAB-zebrafish	experiments	and	contributed	to	the	writing	of	the	manuscript.	
A.	S.	B.	and	S.	D.	S.	O.	performed	HAB	phenotypic	screening.	M.	B.	and	 I.	C.	B.	performed	the	fluorescence	spectroscopy	
experiments.	B.	S.	M.	provided	with	human	neutrophils	and	PBMC.	K.	L.	performed	the	HRMS	analysis.		P.	H.	assisted	with	
helpful	 discussion	 and	 participated	 in	 the	 writing	 of	 the	manuscript.	 R.	 D.	 designed	HAB,	 performed	 the	 synthesis	 and	
structural	analysis	of	all	compounds,	performed	 logD7.4	measurements,	co-analysed	all	biological	experiments,	and	wrote	
the	manuscript. 
 
Additional	information	 
Electronic	 Supplementary	 Information	 (ESI)	 such	 as	 detailed	 experimental	 procedures	 regarding	 compound	 synthesis,	
structural	 and	 spectral	 characterization,	 pKa	 prediction,	 bioimaging	 experiments,	 staining	 dynamics	 of	 HAB	 in	 72	 hpf	
zebrafish	larvae	(videos)	and	complementary	figures,	accompanies	this	article	at	http://rsc.org/chemicalscience.	 
 
Competing	financial	interests:	the	authors	declare	no	competing	financial	interests.	 
 
How	to	cite	this	article:	 
	
	
	
	
	
	
	
